Why Piedmont Global
Clinical research succeeds when communication is clear, compliance is airtight, and patients feel represented. Yet too many trials stall because limited English proficient (LEP) populations are excluded from participation.
Piedmont Global embeds with your teams to align people, processes, and technology across the life sciences lifecycle — from protocol design to labeling and market release. We call it Strategic Globalization. You can call it faster enrollment, regulator-ready documentation, and treatments that reach more patients, sooner.
Industry Challenge
The hidden barriers to clinical trial participation
From consent to commercialization
Our strategic approach
We partner with sponsors, CROs, and research sites to embed cultural fluency and compliance expertise at every stage.
Multilingual patient outreach
Recruitment campaigns localized with cultural nuance to build trust from the start.
Informed consent clarity
Written translations and live interpretation so participants understand risks and benefits.
Regulatory alignment
Processes designed to meet FDA, EMA, and ICH-GCP standards.
Global labeling & submissions
Accurate, regulator-ready content for faster approval and launch.
Data integrity & security
Secure workflows that safeguard sensitive medical and trial information
Smarter trials. Stronger outcomes.
With Piedmont Global as your partner, you can:
- Improve enrollment and retention among LEP populations
- Mitigate regulatory and compliance risk
- Accelerate trial timelines and reduce costly delays
- Build public trust in research outcomes
- Deliver science that reflects the diversity of real-world population